Gene · 211
Papers1,411
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,411
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long-term management and treatment of acute intermittent porphyria with recurring attacks using pharmacological prophylaxis. | Hepatol Commun | 2023 | 38051544 | PubTator, text mining | PubMed |
| Rational optimization of a transcription factor activation domain inhibitor. | Nat Struct Mol Biol | 2023 | 38049566 | PubTator, text mining | PubMed |
| Unleashing the potential of catalytic RNAs to combat mis-spliced transcripts. | Front Bioeng Biotechnol | 2023 | 38047291 | PubTator, text mining | PubMed |
| Antisense oligonucleotides: a novel Frontier in pharmacological strategy. | Front Pharmacol | 2023 | 38044945 | PubTator, text mining | PubMed |
| CRM1 expression: association with high prognostic value in laryngeal cancer. | Turk J Med Sci | 2023 | 38031942 | PubTator, text mining | PubMed |
| Erythropoietic protoporphyria: case reports for clinical and therapeutic hints. | Ital J Pediatr | 2023 | 37996925 | PubTator, text mining | PubMed |
| Acute intermittent porphyria complicated with acute pancreatitis: A case report and literature review. | Medicine (Baltimore) | 2023 | 37986312 | PubTator, text mining | PubMed |
| Inhibition of ALA dehydratase activity in heme biosynthesis reduces cytoglobin expression which is related to the proliferation and viability of keloid fibroblasts. | J Clin Biochem Nutr | 2023 | 37970551 | PubTator, text mining | PubMed |
| Characterization of NFE2L1-616, an isoform of nuclear factor-erythroid-2 related transcription factor-1 that activates antioxidant response element-regulated genes. | Sci Rep | 2023 | 37963997 | PubTator, text mining | PubMed |
| SARS-CoV-2 hijacks a cell damage response, which induces transcription of a more efficient Spike S-acyltransferase. | Nat Commun | 2023 | 37952051 | PubTator, text mining | PubMed |
| ReDirection: an R-package to compute the probable dissociation constant for every reaction of a user-defined biochemical network. | Front Mol Biosci | 2023 | 37942290 | PubTator, text mining | PubMed |
| Transcriptomic analyses reveal proinflammatory activation of human brain microvascular endothelial cells by aging-associated peptide medin and reversal by nanoliposomes. | Sci Rep | 2023 | 37914766 | PubTator, text mining | PubMed |
| A novel mutation c.457C > T p.Q153 in the HMBS gene in a Mexican woman with acute intermittent porphyria. | Clin Case Rep | 2023 | 37900716 | PubTator, text mining | PubMed |
| An approach for collaborative development of a federated biomedical knowledge graph-based question-answering system: Question-of-the-Month challenges. | J Clin Transl Sci | 2023 | 37900350 | PubTator, text mining | PubMed |
| Molecular Mechanisms Provide a Landscape for Biomarker Selection for Schizophrenia and Schizoaffective Psychosis. | Int J Mol Sci | 2023 | 37894974 | PubTator, text mining | PubMed |
| Effects of exercise on circadian rhythms in humans. | Front Pharmacol | 2023 | 37886134 | PubTator, text mining | PubMed |
| An Analysis and Literature Review of a Family Case of Acute Intermittent Porphyria With Initial Symptoms of Epileptic Seizure. | Cureus | 2023 | 37872925 | PubTator, text mining | PubMed |
| Needle in a Haystack: Acute Intermittent Porphyria, an Often-missed Differential Diagnosis of Abdominal Pain. | J Community Hosp Intern Med Perspect | 2023 | 37868674 | PubTator, text mining | PubMed |
| Targeting Angiotensinogen With N-Acetylgalactosamine-Conjugated Small Interfering RNA to Reduce Blood Pressure. | Arterioscler Thromb Vasc Biol | 2023 | 37855126 | PubTator, text mining | PubMed |
| Sigma Receptors: Novel Regulators of Iron/Heme Homeostasis and Ferroptosis. | Int J Mol Sci | 2023 | 37834119 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/211/papers?page=5